241 related articles for article (PubMed ID: 35436499)
1. The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses.
Saud Z; Tyrrell VJ; Zaragkoulias A; Protty MB; Statkute E; Rubina A; Bentley K; White DA; Rodrigues PDS; Murphy RC; Köfeler H; Griffiths WJ; Alvarez-Jarreta J; Brown RW; Newcombe RG; Heyman J; Pritchard M; Mcleod RW; Arya A; Lynch CA; Owens D; Jenkins PV; Buurma NJ; O'Donnell VB; Thomas DW; Stanton RJ
J Lipid Res; 2022 Jun; 63(6):100208. PubMed ID: 35436499
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection.
O'Donnell VB; Thomas D; Stanton R; Maillard JY; Murphy RC; Jones SA; Humphreys I; Wakelam MJO; Fegan C; Wise MP; Bosch A; Sattar SA
Function (Oxf); 2020; 1(1):zqaa002. PubMed ID: 33215159
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of
Idrees M; McGowan B; Fawzy A; Abuderman AA; Balasubramaniam R; Kujan O
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231450
[TBL] [Abstract][Full Text] [Related]
4. Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.
Muñoz-Basagoiti J; Perez-Zsolt D; León R; Blanc V; Raïch-Regué D; Cano-Sarabia M; Trinité B; Pradenas E; Blanco J; Gispert J; Clotet B; Izquierdo-Useros N
J Dent Res; 2021 Oct; 100(11):1265-1272. PubMed ID: 34282982
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effect of mouthwashes against SARS-COV-2: A systematic review.
Mezarina Mendoza JPI; Trelles Ubillús BP; Salcedo Bolívar GT; Castañeda Palacios RDP; Herrera Lopez PSG; Padilla Rodríguez DA; Uchima Koecklin KH
Saudi Dent J; 2022 Mar; 34(3):167-193. PubMed ID: 35125835
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence.
Chen MH; Chang PC
J Formos Med Assoc; 2022 May; 121(5):879-885. PubMed ID: 34666923
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2.
Carrouel F; Gonçalves LS; Conte MP; Campus G; Fisher J; Fraticelli L; Gadea-Deschamps E; Ottolenghi L; Bourgeois D
J Dent Res; 2021 Feb; 100(2):124-132. PubMed ID: 33089717
[TBL] [Abstract][Full Text] [Related]
8. Cetylpyridinium Chloride-Containing Mouthwashes Show Virucidal Activity against Herpes Simplex Virus Type 1.
Riveira-Muñoz E; Garcia-Vidal E; Bañó-Polo M; León R; Blanc V; Clotet B; Ballana E
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515121
[TBL] [Abstract][Full Text] [Related]
9. Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.
Alzahrani MM; Bamashmous S; Alkharobi H; Alghamdi A; Alharbi RH; Hassan AM; Darwish M; Bukhari A; Mahmoud AB; Alfaleh MA; Mirza AA; Abuzenadah AM; Abujamel TS; Hashem AM
J Med Virol; 2023 Jan; 95(1):e28412. PubMed ID: 36527332
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of mouth rinses against COVID-19: a systematic review and network meta-analysis.
Lin SY; Sun JS; Hung MC; Chang JZ
J Hosp Infect; 2023 Sep; 139():175-191. PubMed ID: 37419189
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F
J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
[TBL] [Abstract][Full Text] [Related]
14. CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva.
Anderson ER; Patterson EI; Richards S; Pitol AK; Edwards T; Wooding D; Buist K; Green A; Mukherjee S; Hoptroff M; Hughes GL
J Med Microbiol; 2022 Feb; 71(2):. PubMed ID: 35180046
[No Abstract] [Full Text] [Related]
15. Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials.
D'Amico F; Moro M; Saracino M; Marmiere M; Cilona MB; Lloyd-Jones G; Zangrillo A
Mol Oral Microbiol; 2023 Jun; 38(3):171-180. PubMed ID: 36808889
[TBL] [Abstract][Full Text] [Related]
16. Effective
Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
[TBL] [Abstract][Full Text] [Related]
17. Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial.
Alemany A; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Ouchi D; Laporte-Villar C; Baro B; Henríquez N; Prat N; Gianinetto MO; Gutiérrez MV; Sánchez-Paniagua MG; Henríquez NL; Vicente JM; Ara J; Rodriguez-Arias MA; Puig J; Blanco I; Lopez CC; Hernández Á; Bordoy AE; Redondo CE; Soler VG; Giménez M; Blanc V; León R; Gispert J; ; Clotet B; Izquierdo-Useros N; Mitjà O
J Dent Res; 2022 Nov; 101(12):1450-1456. PubMed ID: 35727681
[TBL] [Abstract][Full Text] [Related]
18. Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2.
Takeda R; Sawa H; Sasaki M; Orba Y; Maishi N; Tsumita T; Ushijima N; Hida Y; Sano H; Kitagawa Y; Hida K
Sci Rep; 2022 Aug; 12(1):14050. PubMed ID: 35982118
[TBL] [Abstract][Full Text] [Related]
19. Oral antiseptics against coronavirus: in-vitro and clinical evidence.
Mateos-Moreno MV; Mira A; Ausina-Márquez V; Ferrer MD
J Hosp Infect; 2021 Jul; 113():30-43. PubMed ID: 33865974
[TBL] [Abstract][Full Text] [Related]
20. An exploratory study of drug concentration and inhibitory effect of cetylpyridinium chloride buccal tablets on SARS-CoV-2 infection among 10 Chinese subjects.
Li Y; Xie Z; Chen L; Liu X; Li S; Ye S; Tang H; Lee C; Gu Q; Men F; Zhang J; Hu D; Jiang Y; Wang X; Wang Q; Feng Y; Niu S; Liu Y; Fang Y
Fundam Clin Pharmacol; 2024 Jun; 38(3):579-587. PubMed ID: 37985697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
